Cresset Asset Management, LLC Harmony Biosciences Holdings, Inc. Transaction History
Cresset Asset Management, LLC
- $20.6 Billion
- Q1 2024
A detailed history of Cresset Asset Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 50,862 shares of HRMY stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,862Holding current value
$1.53 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$337 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$178 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$109 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$78.2 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$74.8 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.77B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...